
Overview
Roy Tishler is a Radiation Oncologist in Boston, Massachusetts. Dr. Tishler is highly rated in 22 conditions, according to our data. His top areas of expertise are Merkel Cell Carcinoma, Teratocarcinosarcoma, Olfactory Neuroblastoma, Renal Oncocytoma, and Gastrostomy.
His clinical research consists of co-authoring 80 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Awards
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
75 Francis Street, Boston, MA 02115
450 Brookline Avenue, Boston, MA 02115
450 Brookline Avenue, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Brian Alexander is a Radiation Oncologist in Boston, Massachusetts. Dr. Alexander is highly rated in 19 conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, Glioma, and Tissue Biopsy.
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is highly rated in 17 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Massachusetts General Physicians Organization Inc
Helen Shih is a Radiation Oncologist in Boston, Massachusetts. Dr. Shih is highly rated in 24 conditions, according to our data. Her top areas of expertise are Meningioma, Brain Tumor, Astrocytoma, Acoustic Neuroma, and Tissue Biopsy. Dr. Shih is currently accepting new patients.
Frequently Asked Questions about Dr. Roy B. Tishler
How do I make an appointment with Dr. Roy B. Tishler?
You can book an appointment with Dr. Roy B. Tishler by calling their office at 617-632-5296. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Roy B. Tishler a top-rated expert for Merkel Cell Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Roy B. Tishler is classified as an Distinguished expert for Merkel Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Roy B. Tishler specialize in?
While Dr. Roy B. Tishler is a Radiation Oncology, they have specific expertise in Merkel Cell Carcinoma, Teratocarcinosarcoma, and Olfactory Neuroblastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Roy B. Tishler participate in research or clinical trials?
Yes. Dr. Roy B. Tishler has published 80 articles and abstracts on conditions like Merkel Cell Carcinoma. You can view a list of Dr. Roy B. Tishler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Roy B. Tishler accept my insurance?
Dr. Roy B. Tishler accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 617-632-5296 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Head and Neck Squamous Cell Carcinoma (HNSCC)Dr. Tishler isDistinguished. Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
- Merkel Cell CarcinomaDr. Tishler isDistinguished. Learn about Merkel Cell Carcinoma.
- Olfactory NeuroblastomaDr. Tishler isDistinguished. Learn about Olfactory Neuroblastoma.
- Renal OncocytomaDr. Tishler isDistinguished. Learn about Renal Oncocytoma.
- TeratocarcinosarcomaDr. Tishler isDistinguished. Learn about Teratocarcinosarcoma.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Tishler isAdvanced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Tishler isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Tishler isAdvanced. Learn about Alveolar Soft Part Sarcoma.
- Angiosarcoma of the ScalpDr. Tishler isAdvanced. Learn about Angiosarcoma of the Scalp.
- Epithelioid SarcomaDr. Tishler isAdvanced. Learn about Epithelioid Sarcoma.
- Experienced
- Anaplastic Thyroid CancerDr. Tishler isExperienced. Learn about Anaplastic Thyroid Cancer.
- Bone TumorDr. Tishler isExperienced. Learn about Bone Tumor.
- Eccrine PorocarcinomaDr. Tishler isExperienced. Learn about Eccrine Porocarcinoma.
- Epithelial-Myoepithelial CarcinomaDr. Tishler isExperienced. Learn about Epithelial-Myoepithelial Carcinoma.
- Ewing SarcomaDr. Tishler isExperienced. Learn about Ewing Sarcoma.
- Follicular Thyroid CancerDr. Tishler isExperienced. Learn about Follicular Thyroid Cancer.
